Pregnancies in patients with autoimmune disease receiving CAR T-cell therapy
Schett, Georg
creator
Autor
Wirsching, Andreas
Rothe, Tobias
Visconti, Vanessa
Kramer, Neil
text
pe
monographic
spa
eng
páginas: 821-824
Autoimmune diseases preferentially affect women in their childbearing years, potentially interfering with reproduction. Pregnancies in patients with autoimmune diseases are associated with increased maternal and fetal risks. Treatment of autoimmune diseases with autologous CD19–chimeric antigen receptor (CAR) T cells has been shown to lead to sustained drug-free remission, which is expected to be associated with improved pregnancy outcomes.
ENFERMEDAD AUTOINMUNE
COMPLICACIONES DEL EMBARAZO
ENDOCRINOLOGÍA GENERAL
CÉLULAS T
The New England Journal of Medicine
Massachusetts NEJM Group
NEJM12
0028-4793
ESSALUD
BMG
20260821151611.0
ESSALUD